Gil Efron to Step Down as CEO in August 2026 for Health Considerations; Will Continue to Lead Corporate DevelopmentREHOVOT, Israel, March 13, ...

Gil Efron to Step Down as CEO in August 2026 for Health Considerations; Will Continue to Lead Corporate Development REHOVOT, Israel, March 13, 2026 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. (NASDAQ/TASE ...

Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q4 2025 Earnings Call Transcript March 12, 2026 Allogene Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.17, expectations were $-0.22551.

Application supported by Phase 3 data reinforcing teclistamab regimens as a potential standard of care after at least one prior therapy1 ...

Combination demonstrates deep PSA responses and favorable safety profile with plans to advance into Phase 3 Data highlight the potential of this first-in-class next-generation ...

As we close 2025 and enter what we expect to be a defining year for Allogene Therapeutics, Inc., the environment around us is shifting. Cell therapy has entered a phase defined by evidence, where ...

Alithea Genomics, an emerging leader in the field of large-scale RNA sequencing and transcriptomics, announced today the closing of its seed financing round with an additional CHF 3 million ($3.9 ...

Detailed price information for Fate Therapeutics (FATE-Q) from The Globe and Mail including charting and trades.

Peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS), is a rare subtype of non-Hodgkin lymphoma that frequently presents with multiorgan involvement. We report a diagnostically challenging ...

U.S. House Rep. Jeff Hurd, the Grand Junction Republican representing Colorado’s 3rd Congressional District, held a telephone town hall Wednesday night, with more than 14,000 constituents listening in ...

Don C. will host Complex Market as it takes over Ace & Mission Studios in the heart of DTLA on Saturday, February 14. The event will showcase over 30 carefully curated brands, artists, games, and ...

Dentistry is one of healthcare's most data-dense environments: every patient encounter produces radiographs, clinical findings, periodontal measurements, treatment plans, codes, and narrative decision ...